These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 7667677)

  • 1. Critique of reductionistic models of obsessive-compulsive disorder: toward a new explanatory paradigm.
    Franzblau SH; Kanadanian M; Rettig E
    Soc Sci Med; 1995 Jul; 41(1):99-112. PubMed ID: 7667677
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The inference-based approach to obsessive-compulsive disorder: A comprehensive review of its etiological model, treatment efficacy, and model of change.
    Julien D; O'Connor K; Aardema F
    J Affect Disord; 2016 Sep; 202():187-96. PubMed ID: 27262641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peripheral markers of serotonin and dopamine function in obsessive-compulsive disorder.
    Marazziti D; Hollander E; Lensi P; Ravagli S; Cassano GB
    Psychiatry Res; 1992 Apr; 42(1):41-51. PubMed ID: 1603880
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Compulsivity in obsessive-compulsive disorder and addictions.
    Figee M; Pattij T; Willuhn I; Luigjes J; van den Brink W; Goudriaan A; Potenza MN; Robbins TW; Denys D
    Eur Neuropsychopharmacol; 2016 May; 26(5):856-68. PubMed ID: 26774279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurobiology of obsessive compulsive disorder--a serotonergic basis of Freudian repression.
    Katz RJ
    Neurosci Biobehav Rev; 1991; 15(3):375-81. PubMed ID: 1956605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mood-related obsessive-compulsive symptoms in a patient with bipolar affective disorder.
    Gordon A; Rasmussen SA
    J Clin Psychiatry; 1988 Jan; 49(1):27-8. PubMed ID: 3335487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psychodynamic and cognitive-behavioral approaches of obsessive-compulsive disorder: is it time to work through our ambivalence?
    Kempke S; Luyten P
    Bull Menninger Clin; 2007; 71(4):291-311. PubMed ID: 18254688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Animal models of obsessive-compulsive disorder: rationale to understanding psychobiology and pharmacology.
    Korff S; Harvey BH
    Psychiatr Clin North Am; 2006 Jun; 29(2):371-90. PubMed ID: 16650714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The neuroethological approach to obsessive-compulsive disorder.
    Stein DJ; Shoulberg N; Helton K; Hollander E
    Compr Psychiatry; 1992; 33(4):274-81. PubMed ID: 1643870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disgust and obsessive-compulsive disorder: an update.
    Berle D; Phillips ES
    Psychiatry; 2006; 69(3):228-38. PubMed ID: 17040174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Has OCD research gone to the dogs? Comments on "Recent advances in obsessive-compulsive disorder".
    Insel TR
    Neuropsychopharmacology; 1991 Aug; 5(1):13-7; discussion 21-2. PubMed ID: 1930607
    [No Abstract]   [Full Text] [Related]  

  • 12. Obsessive compulsive personality disorder and obsessive compulsive disorder: clinical characteristics, diagnostic difficulties, and treatment.
    Mancebo MC; Eisen JL; Grant JE; Rasmussen SA
    Ann Clin Psychiatry; 2005; 17(4):197-204. PubMed ID: 16402751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Double conflicts model and anxiety ratification therapy hypotheses of obsessive-compulsive disorder.
    Zhang ZM; Zhang ZL; Li H
    Med Hypotheses; 2010 Dec; 75(6):586-9. PubMed ID: 20719437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A new explanatory model for obsessive-compulsive disorder].
    Visser HA; van Megen HJ; van Oppen P; van Balkom AJ
    Tijdschr Psychiatr; 2009; 51(4):227-37. PubMed ID: 19434577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Separating obsessive-compulsive disorder from the self. A qualitative study of family member perceptions.
    Pedley R; Bee P; Berry K; Wearden A
    BMC Psychiatry; 2017 Sep; 17(1):326. PubMed ID: 28882118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. m-Chlorophenylpiperazine in patients with obsessive-compulsive disorder: absence of symptom exacerbation.
    Goodman WK; McDougle CJ; Price LH; Barr LC; Hills OF; Caplik JF; Charney DS; Heninger GR
    Biol Psychiatry; 1995 Aug; 38(3):138-49. PubMed ID: 7578657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psychopathology of obsessive-compulsive disorder: a phenomenological approach.
    Bürgy M
    Psychopathology; 2005; 38(6):291-300. PubMed ID: 16224202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The waking nightmare: an overview of obsessive compulsive disorder.
    Rapoport JL
    J Clin Psychiatry; 1990 Nov; 51 Suppl():25-8. PubMed ID: 2228991
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A review of animal models of obsessive-compulsive disorder: a focus on developmental, immune, endocrine and behavioral models.
    Grados M; Prazak M; Saif A; Halls A
    Expert Opin Drug Discov; 2016; 11(1):27-43. PubMed ID: 26558411
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Obsessive compulsive disorder: a review of possible specific internal representations within a broader cognitive theory.
    Doron G; Kyrios M
    Clin Psychol Rev; 2005 Jun; 25(4):415-32. PubMed ID: 15885864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.